| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/30/2007 | CA2302411C Improved method for preventing crystal formation in a scopolamine transdermal device |
| 01/30/2007 | CA2226886C N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/30/2007 | CA2173208C Levobupivacaine useful for managing chronic pain |
| 01/30/2007 | CA2166704C Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/30/2007 | CA2138991C Treatment for sensitive teeth |
| 01/28/2007 | CA2552831A1 Polysubstitute 1,1-pyridinylaminocyclopropanamine compounds, the process for preparing them and the pharmaceutical formulations that contain them |
| 01/25/2007 | WO2007011833A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/25/2007 | WO2007011810A1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/25/2007 | WO2007011286A1 Therapeutic agents |
| 01/25/2007 | WO2007011285A1 Therapeutic agents |
| 01/25/2007 | WO2007011284A1 Therapeutic agents |
| 01/25/2007 | WO2007010989A1 Neuronal differentiation-inducing peptide and use thereof |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010910A1 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010275A1 Novel epilepsy treatment |
| 01/25/2007 | WO2007010242A1 Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders |
| 01/25/2007 | WO2007010217A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS |
| 01/25/2007 | WO2007009906A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 01/25/2007 | WO2007009801A2 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug |
| 01/25/2007 | WO2007009800A2 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 01/25/2007 | WO2007009788A1 A process and composition for making olanzapine form (i) |
| 01/25/2007 | WO2007009778A1 Piperidine carboxamide derivate suitable as tachykinin receptor antagonist |
| 01/25/2007 | WO2007009777A1 Chemical compounds |
| 01/25/2007 | WO2007009724A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009723A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009722A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009721A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009720A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009708A1 Salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009705A1 (rac)-n-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydr0-1h-pyrazole-3-carboxamide hydrates |
| 01/25/2007 | WO2007009697A1 Quaternary ammonium salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009696A1 Use of substituted pyrazoline compounds for the preparation of paediatric medicaments |
| 01/25/2007 | WO2007009695A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009691A2 Combination of substituted pyrazolines and anti -addictive agent |
| 01/25/2007 | WO2007009690A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009689A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | WO2007009462A2 Treatment of migraine and headaches |
| 01/25/2007 | WO2007009395A1 Schisandrin b preparation |
| 01/25/2007 | WO2006130080A3 Quinoline derivatives as nk3 anatgonists |
| 01/25/2007 | WO2006121861A3 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/25/2007 | WO2006117400A3 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors |
| 01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006101745A3 Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
| 01/25/2007 | WO2006085144A3 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/25/2007 | WO2006078588A3 Improved methods for treating headache |
| 01/25/2007 | WO2006070290A8 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders |
| 01/25/2007 | WO2006061428A3 Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain |
| 01/25/2007 | WO2004047844A8 Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| 01/25/2007 | US20070021607 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/25/2007 | US20070021506 Stress relieving composition |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 01/25/2007 | US20070021406 New neurokinin antagonists for use as medicaments |
| 01/25/2007 | US20070021397 Neurocyte protective agent |
| 01/25/2007 | US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/25/2007 | US20070021393 New use of GabaB receptor agonists |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021355 Antidepressants or foods and beverage for antidepression |
| 01/25/2007 | US20070021348 Novel treatment |
| 01/25/2007 | US20070021335 Agent for improving mental disorders |
| 01/25/2007 | US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020608 Method for the generation of neural progenitor cells |
| 01/25/2007 | US20070020343 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070017513 Method and apparatus for dispensing inhalator medicament |
| 01/25/2007 | US20070017508 Methods for treating jaw pain |
| 01/25/2007 | DE112005000178T5 Verfahren zur Herstellung von Rocuroniumbromid und Zwischenprodukte davon A process for preparing rocuronium bromide and intermediates thereof |
| 01/25/2007 | DE102005032625A1 Use of an agent comprising cocaine derivative and/or degradation product of the cocaine derivative, for the production of medicament to treat neural and neurodegenerative diseases e.g. dementia diseases, Parkinson diseases or depressions |
| 01/25/2007 | CA2616141A1 Novel epilepsy treatment |
| 01/25/2007 | CA2616063A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 01/25/2007 | CA2615813A1 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 01/25/2007 | CA2615676A1 N(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 01/25/2007 | CA2615656A1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/25/2007 | CA2615588A1 Pyrazole derivatives as cb1 modulators |
| 01/25/2007 | CA2615552A1 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 01/25/2007 | CA2615533A1 Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic |
| 01/25/2007 | CA2615236A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | CA2614327A1 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 01/25/2007 | CA2612468A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611366A1 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611364A1 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/24/2007 | EP1746108A1 Fish-origin chondroitin sulfate/dermatan sulfate hybrid chain |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1746092A1 Compounds and methods for treatment of amyloid-B-peptide related disorders |
| 01/24/2007 | EP1745795A2 Pharmaceutical composition for the treatment of multiple sclerosis |
| 01/24/2007 | EP1745788A1 Acyglycerophospholipids for treating cancer and cachexia |
| 01/24/2007 | EP1745786A1 Neuroprotective compounds and pharmaceutical compositions comprising them |